Projects per year
Fingerprint Dive into the research topics where Kevin Winthrop is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Rheumatoid Arthritis
Medicine & Life Sciences
Nontuberculous Mycobacteria
Medicine & Life Sciences
Antirheumatic Agents
Medicine & Life Sciences
Infection
Medicine & Life Sciences
Tumor Necrosis Factor-alpha
Medicine & Life Sciences
Tuberculosis
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Biological Therapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2020
P2 Study of Clofazimine for Pulmonary M. avium Disease IND 125,266 (1/5/2015)
9/1/16 → 7/31/20
Project: Research project
Clofazimine
Mycobacterium avium Complex
Lung
Lung Diseases
Orphan Drug Production
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Curtis, J. R. & Winthrop, K.
9/1/14 → 8/31/19
Project: Research project
Herpes Zoster Vaccine
Chickenpox Vaccine
Herpes Zoster
Safety
Rheumatoid Arthritis
Mycobacterial disease prevention: pharmacovigilance and inflammatory disease
9/30/08 → 9/29/11
Project: Research project
Pharmacovigilance
Biological Therapy
Tumor Necrosis Factor-alpha
Immunosuppressive Agents
Infection
Research Output 1997 2019
1
Citation
(Scopus)
Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research
Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E. L., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 others, , Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.Research output: Contribution to journal › Review article
Lung
Infection
Research
2
Citations
(Scopus)
Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response
Skopelja-Gardner, S., Theprungsirikul, J., Meagher, R. E., Beliveau, C. M., Bradley, K. E., Avery, M., Henkle, E., Siegel, S., Gifford, A. H., Winthrop, K. & Rigby, W. F. C., Feb 1 2019, In : European Respiratory Journal. 53, 2, 1801891.Research output: Contribution to journal › Letter
Bronchiectasis
Autoimmunity
Pseudomonas aeruginosa
Immunoglobulin G
bactericidal permeability increasing protein
Direct-acting antivirals for hepatitis C: Predictors of early discontinuation in the real world
De Ávila Machado, M. A., De Moura, C. S., Klein, M., Winthrop, K., Carleton, B., Abrahamowicz, M., Feld, J., Curtis, J. R., Beauchamp, M. E. & Bernatsky, S., Jan 1 2019, In : Journal of Managed Care and Specialty Pharmacy. 25, 6, p. 697-704 8 p.Research output: Contribution to journal › Article
Hepatitis C
Ritonavir
Antiviral Agents
Viruses
Hepacivirus
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: Results from a long-term extension trial substudy
Winthrop, K., Bingham, C. O., Komocsar, W. J., Bradley, J., Issa, M., Klar, R. & Kartman, C. E., Apr 18 2019, In : Arthritis Research and Therapy. 21, 1, 102.Research output: Contribution to journal › Article
Open Access
Pneumococcal Vaccines
Tetanus Toxoid
Rheumatoid Arthritis
Vaccination
Tetanus
1
Citation
(Scopus)
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial
Singh, J. A., Fraenkel, L., Green, C., Alarcón, G. S., Barton, J., Saag, K. G., Hanrahan, L. M., Raymond, S. C., Kimberly, R. P., Leong, A. L., Reyes, E., Street, R. L., Suarez-Almazor, M. E., Eakin, G. S., Marrow, L., Morgan, C. J., Caro, B., Sloan, J. A., Jandali, B., Garcia, S. R. & 8 others, , May 1 2019, In : PLoS medicine. 16, 5, e1002800.Research output: Contribution to journal › Article
Open Access
Lupus Nephritis
Decision Support Techniques
Randomized Controlled Trials
Pamphlets
Immunosuppressive Agents